Login to Your Account



Hearing offers little 'HELP' in reining in U.S. drug prices

By Mari Serebrov
Regulatory Editor

Tuesday, October 17, 2017

Another congressional hearing on drug prices yielded a familiar clanking about importation, direct Medicare negotiation and transparency, transparency, transparency.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription